The abscopal effect of radiotherapy and nivolumab in relapsed or refractory Hodgkin lymphoma

Spotlight on global cancer control at ASCO 2022

Biomarker analysis of the NeoALTTO trial provides oncofertility insight for younger breast cancer patients

ASCO 2022: Breast cancer highlights

Updated data from the Phase 1/2 MajesTEC-1 study evaluating teclistamab, a BCMA x CD3 bispecific antibody

CheckMate 9ER: aRCC patients on nivolumab plus cabozantinib achieved deeper responses vs sunitinib

COSMIC-021: Cabozantinib plus atezolizumab gives encouraging clinical activity in inoperable locally advanced/metastatic urothelial carcinoma

Circulating tumour DNA analysis can help identify the need for adjuvant therapy in stage II colon cancer

Ibrutinib improves PFS by 50% for older patients with newly diagnosed mantle cell lymphoma

UICC announces global coalition to increase access to essential cancer medicines in low and lower middle-income countries

Sacituzumab govitecan increases PFS for HR+/HER2- metastatic breast cancer

Cancer Services Delivery: Focus on India